As previous studies have demonstrated that high doses of free CDN (20–100 μg) were required for efficacy12, we also evaluated a 30 μg dose of free CDN2, which rapidly cleared from the injected tumor and was detectable in the plasma by 30-min. This evidence concerns the gene NT5C and neoplasm.